dna helix

On Thursday, a federal appeals court found that Myriad Genetics could maintain its patents related to the BRCA1 and BRCA2 genes.

( National Human Genome Research Institute )

On Thursday, a federal appeals court found that Myriad Genetics could maintain its patents related to the BRCA1 and BRCA2 genes.

  • Email E-mail
  • add to Twitter Twitter
  • add to Facebook Facebook

PLAN AHEAD

Top Trending Videos